Cornelia Kolberg-Liedtke

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 02, 2022
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.

Cornelia Kolberg-Liedtke, Friedrich Feuerhake, Madlen Garke

|May 16, 2020
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.

Cornelia Kolberg-Liedtke, Oleg Gluz, Fred Heinisch

Pageof 1

Frequent Collaborators